Bristol Myers Squibb tie-up would be one of biggest-ever pharma deals and create world’s fourth-largest drugmaker
Business live – latest updates
Britain’s biggest drugmaker, AstraZeneca, is understood to be in discussions to take over its US rival Bristol Myers Squibb in a deal that would create a near-$400bn (£300bn) pharmaceutical group.
AstraZeneca, run by Pascal Soriot, its longtime chief executive, is the second-biggest listed company in the UK, with a market value of nearly £196bn before the news broke. BMS, headquartered in Princeton and known for its cancer treatments, is worth $133bn.
Continue reading…
Source link : https://www.theguardian.com/business/2026/aug/03/astrazeneca-talks-bristol-myers-squibb-merger-pharmaceuticals
Author : Julia Kollewe
Publish date : 2026-08-03 10:22:00
Copyright for syndicated content belongs to the linked Source.
